UK markets close in 7 hours 44 minutes

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.90+0.75 (+8.20%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
0
22,334
59,215
103,269
173,245
Cost of revenue
0
5,742
12,125
17,516
16,301
Gross profit
0
16,592
47,090
85,753
156,944
Operating expenses
Research development
21,469
20,442
32,917
39,329
33,418
Selling general and administrative
43,583
32,405
30,183
100,359
58,860
Total operating expenses
65,052
53,253
63,916
146,307
95,937
Operating income or loss
-65,052
-36,661
-16,826
-60,554
61,007
Interest expense
10,426
12,994
12,483
10,622
1,052
Total other income/expenses net
5,207
44,573
-9,273
-42,021
32,705
Income before tax
-70,271
-5,082
-38,582
-113,197
92,660
Income tax expense
-14,264
-12,110
-5,356
-17,893
24,389
Income from continuing operations
-56,007
7,028
-33,226
-95,304
68,271
Net income
-56,007
7,028
-33,226
-95,304
68,271
Net income available to common shareholders
-56,007
7,028
-33,226
-95,304
68,271
Basic EPS
-
0.13
-0.89
-2.55
1.66
Diluted EPS
-
0.13
-0.89
-2.55
1.61
Basic average shares
-
52,996
37,403
37,325
40,465
Diluted average shares
-
54,941
37,403
37,325
41,765
EBITDA
-
9,602
-23,613
-95,145
98,595